6.
Berry J, Jay N, Cranston R, Darragh T, Holly E, Welton M
. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2013; 134(5):1147-55.
DOI: 10.1002/ijc.28431.
View
7.
Tian T, Mijiti P, Bingxue H, Fadong Z, Ainiwaer A, Guoyao S
. Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China. PLoS One. 2017; 12(11):e0187928.
PMC: 5687769.
DOI: 10.1371/journal.pone.0187928.
View
8.
Chaturvedi A
. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health. 2010; 46(4 Suppl):S20-6.
DOI: 10.1016/j.jadohealth.2010.01.016.
View
9.
de Martel C, Plummer M, Vignat J, Franceschi S
. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664-670.
PMC: 5520228.
DOI: 10.1002/ijc.30716.
View
10.
Safaeian F, Ghaemimood S, El-Khatib Z, Enayati S, Mirkazemi R, Reeder B
. Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study. JMIR Public Health Surveill. 2021; 7(5):e22160.
PMC: 8156112.
DOI: 10.2196/22160.
View
11.
Lin C, Franceschi S, Clifford G
. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2017; 18(2):198-206.
PMC: 5805865.
DOI: 10.1016/S1473-3099(17)30653-9.
View
12.
Palefsky J, Giuliano A, Goldstone S, Moreira Jr E, Aranda C, Jessen H
. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011; 365(17):1576-85.
DOI: 10.1056/NEJMoa1010971.
View
13.
Stanley M, Winder D, Sterling J, Goon P
. HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer. 2012; 12:398.
PMC: 3488563.
DOI: 10.1186/1471-2407-12-398.
View
14.
Giuliano A, Palefsky J, Goldstone S, Moreira Jr E, Penny M, Aranda C
. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011; 364(5):401-11.
PMC: 3495065.
DOI: 10.1056/NEJMoa0909537.
View
15.
Meites E, Wilkin T, Markowitz L
. Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States. Hum Vaccin Immunother. 2022; 18(1):2016007.
PMC: 8993076.
DOI: 10.1080/21645515.2021.2016007.
View
16.
Harper D, DeMars L
. HPV vaccines - A review of the first decade. Gynecol Oncol. 2017; 146(1):196-204.
DOI: 10.1016/j.ygyno.2017.04.004.
View
17.
Liu L, Zhang G, Zhang Z, Wang L, Wang D, Dai J
. Reinfection of Nine-Valent Human Papillomavirus Vaccine Types Among HIV-Negative Men Who Have Sex With Men: A Prospective Cohort Study. Front Public Health. 2022; 10:896479.
PMC: 9340213.
DOI: 10.3389/fpubh.2022.896479.
View
18.
Dona M, Giuliani M, Rollo F, Vescio M, Benevolo M, Giglio A
. Incidence and clearance of anal high-risk Human Papillomavirus infection and their risk factors in men who have sex with men living with HIV. Sci Rep. 2022; 12(1):184.
PMC: 8741812.
DOI: 10.1038/s41598-021-03913-5.
View
19.
Nyitray A, Fujimoto K, Zhao J, Giuliano A, Schneider J, Hwang L
. Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in a Sample of Young, Predominantly Black Men Who Have Sex With Men, Houston, Texas. J Infect Dis. 2017; 217(5):777-784.
PMC: 5853382.
DOI: 10.1093/infdis/jix617.
View
20.
Patel P, Bush T, Conley L, Unger E, Darragh T, Henry K
. Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study. J Infect Dis. 2019; 222(2):234-242.
PMC: 11519787.
DOI: 10.1093/infdis/jiz425.
View